These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15062167)
1. Is an 192Ir permanent seed implant feasible for prostate brachytherapy? Glasgow GP; Dogan N; Mohideen N Brachytherapy; 2002; 1(4):195-203. PubMed ID: 15062167 [TBL] [Abstract][Full Text] [Related]
2. Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds. Maguire PD; Waterman FM; Dicker AP Tech Urol; 2000 Jun; 6(2):85-8. PubMed ID: 10798805 [TBL] [Abstract][Full Text] [Related]
5. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98. International Commission on Radiological Protection Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284 [TBL] [Abstract][Full Text] [Related]
6. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy. Al-Qaisieh B; Brearley E; St Clair S; Flynn A Int J Radiat Oncol Biol Phys; 2006 May; 65(1):304-7. PubMed ID: 16618585 [TBL] [Abstract][Full Text] [Related]
7. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998 [TBL] [Abstract][Full Text] [Related]
8. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Nickers P; Thissen B; Jansen N; Deneufbourg JM Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365 [TBL] [Abstract][Full Text] [Related]
9. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry. Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092 [TBL] [Abstract][Full Text] [Related]
10. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs. Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275 [TBL] [Abstract][Full Text] [Related]
11. Effect of random seed placement error in permanent transperineal prostate seed implant. Bues M; Holupka EJ; Meskell P; Kaplan ID Radiother Oncol; 2006 Apr; 79(1):70-4. PubMed ID: 16515813 [TBL] [Abstract][Full Text] [Related]
12. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Wust P; von Borczyskowski DW; Henkel T; Rosner C; Graf R; Tilly W; Budach V; Felix R; Kahmann F Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144 [TBL] [Abstract][Full Text] [Related]
13. The effect of the radial function on I-125 seeds used for permanent prostate implantation. Pickett B; Pouliot J Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917 [TBL] [Abstract][Full Text] [Related]
14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
15. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. Crook JM; Potters L; Stock RG; Zelefsky MJ Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218 [TBL] [Abstract][Full Text] [Related]
16. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy. Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608 [TBL] [Abstract][Full Text] [Related]
17. [Advances in brachytherapy--focusing on the permanent implant for early prostate carcinoma]. Hirokawa Y Gan To Kagaku Ryoho; 2003 Dec; 30(13):2056-61. PubMed ID: 14712765 [TBL] [Abstract][Full Text] [Related]